Location History:
- Wavre, BE (2002 - 2008)
- Rixensart, BE (2008 - 2017)
Company Filing History:
6 out of 75 
4 out of 531 
Years Active: 2002-2017
Title: **Nathalie Garcon: Innovator in Vaccine Development**
Introduction
Nathalie Garcon, an accomplished inventor based in Rixensart, Belgium, has made significant contributions to the field of immunology, particularly in vaccine development. With 10 patents to her name, Garcon has demonstrated a commitment to advancing public health through innovative solutions.
Latest Patents
Among her notable innovations, Nathalie has developed a vaccine and adjuvant formulation which includes an immunostimulant combined with a metal salt. This groundbreaking formulation focuses on particles that are essentially devoid of antigen, enhancing the efficacy of the vaccine. Additionally, she has pioneered methods for one-dose intradermal delivery of a non-live trivalent influenza vaccine, specifically aimed at facilitating the administration of split influenza preparations. These latest patents illustrate her vast expertise and innovative mindset in the realm of vaccine technology.
Career Highlights
Throughout her career, Nathalie has held pivotal roles at renowned organizations, including SmithKline Beecham Biologicals S.A. and GlaxoSmithKline Biologicals S.A. Her work in these entities has contributed to major advancements in vaccine production and delivery methods.
Collaborations
Nathalie has collaborated with various notable professionals in her field. Among them are Martin Friede and Catherine Marie Ghislaine Gerard, with whom she has shared insights and expertise, further enriching her contributions to vaccine innovation.
Conclusion
Nathalie Garcon's drive for innovation and her impressive portfolio of patents reflect her vital role in the advancement of vaccine technology. Through her latest patents and collaborative efforts, she continues to push the boundaries of immunology, aiming to improve public health outcomes globally.